...
The variables transposed are:
| Dataset | Value | Where | Variable | Variable Label |
|---|
| ADCVNTPR | AVAL | PARAMCD ="BNPPRONT" | BNPPRONT | N-Terminal ProB-type Natriuretic Peptide (IU/L) |
| ADCVNTPR | CHGCAT1 | PARAMCD ="BNPPRONT" | BNPPRCHG | N-Term ProB-type N Pep Change Category |
| Dataset wrap |
|---|
|
| Rowcaps |
|---|
| Rows 1-4: | Show the baseline CMR ejection fraction measurements for participant 101 at VISIT 1. | | Row 5: | Shows the baseline NTProbTest for participant 101 at VISIT 1. | | Rows 6-9: | Show the CMR ejection fraction measurements for participant 101 at VISIT 6. | | Row 10: | Shows the NTProbTest for participant 101 at VISIT 6. | | Dataset2 |
|---|
| | Row | STUDYID | USUBJID | ASEQ | BSABASE | BNPPRONT | BNPPRCHG | PARAM | PARAMCD | PARAMN | AVAL | AVISIT | AVISITN | VISIT | ADT | ABLFL | BASE | CHG | PCHG | TRT01P | ITTFL | AGE | AGEU | SEX | SRCDOM | SRCSEQ |
|---|
| 1 | DMD-EFLGE | DMD-EFLGE-101 | 1 | 0.65 | 40 |
| Left Ventricular Ejection Fraction, Calculated (%) | LVEFC | 1 | 67 | Visit 1 (Month 1) | 1 | VISIT 1 | 16May2022 | Y | 67 |
|
| Treatment A | Y | 8 | YEARS | M | CV | 3 | | 2 | DMD-EFLGE | DMD-EFLGE-101 | 2 | 0.65 | 40 |
| Right Ventricular Ejection Fraction, Calculated (%) | RVEFC | 2 | 74 | Visit 1 (Month 1) | 1 | VISIT 1 | 16May2022 | Y | 74 |
|
| Treatment A | Y | 8 | YEARS | M | CV | 7 | | 3 | DMD-EFLGE | DMD-EFLGE-101 | 43 | 0.65 | 900 | >1.0 (IU/L) | Left Ventricular Ejection Fraction, Calculated (%) | LVEFC | 1 | 60 | Visit 6 (Month 12) | 6 | VISIT 6 | 01Jun2023 |
| 67 | -7 | -10.447761 | Treatment A | Y | 8 | YEARS | M | CV | 11 | | 4 | DMD-EFLGE | DMD-EFLGE-101 | 54 | 0.65 | 900 | >1.0 (IU/L) | Right Ventricular Ejection Fraction, Calculated (%) | RVEFC | 2 | 61 | Visit 6 (Month 12) | 6 | VISIT 6 | 01Jun2023 |
| 74 | -13 | -17.567568 | Treatment A | Y | 8 | YEARS | M | CV | 15 |
|
|
...